Wilding sostiene che lo stesso potrebbe valere per le persone che assumono un GLP-1 RA per un periodo circoscritto: " possibile che [il farmaco] migliori in parte la salute futura
Emerging studies provided evidence that SGLT2-i might have an interfering effect on ARR
Malhotra A, Grunstein RR, Fietze I, et al
Conclusion - This study demonstrates that GLP1 analog use is associated with a significantly lower risk of all-cause mortality and cirrhosis-related complications
The development of melanoma is thought to be rare, although a recent case report was published of a 64-year-old woman who developed nodular achromic melanoma within a nevus spilus [71]
Key exclusion criteria included other medications impacting weight, unstable medical illness, active substance use disorder, and dual antipsychotic use